Why Are Stocks Making Biggest Pre-Market Moves Today? Monday August 10 Pre-Bell Gainers

Monday, August 10, 2026 — Pre-market trading is showing heavy action this morning, with several Tier 1 stocks moving 4-8% before the bell. The catalyst mix includes better-than-expected earnings reports, analyst upgrades, and positive clinical trial data. Volume across the top movers is running 2.1x to 3.8x the 30-day average, signaling institutional interest rather than retail noise.

Here's the breakdown of why certain stocks are moving significantly in the pre-market, what the moves mean for your portfolio, and the key levels to watch when the market opens at 9:30 a.m. ET.

What's Driving Pre-Market Movers Today

Nvidia (NVDA) is the standout performer in pre-market trading, up 6.2% to $142.34 on 12.8M shares traded versus the 30-day average of 4.4M. The catalyst: a weekend announcement that a major hyperscaler has committed to a $8.2B order for Nvidia's next-generation H100X AI accelerators, signaling continued demand in the artificial intelligence infrastructure buildout. This is the largest single order Nvidia has disclosed since Q4 2025 when data center revenue hit an all-time high of $18.4B.

Pfizer (PFE) is moving 4.7% higher in pre-market to $31.18 after reporting Q2 earnings that beat Wall Street expectations. The pharmaceutical giant posted EPS of $0.68 versus the $0.61 consensus estimate — a 11.5% beat. More oncology revenue surged 23% year-over-year to $4.2B, driven by the continued commercial success of their GLP-1 weight-loss medication lineup. This growth rate is double what analysts were modeling for the segment.

Broadcom (AVGO) is up 5.1% pre-market to $189.42 on 3.2M shares (3.1x average volume). The semiconductor infrastructure supplier upgraded guidance late Friday after reporting better-than-expected AI switching chip demand from data center customers preparing for the fall infrastructure refresh cycle. Broadcom's networking revenue, which supplies the infrastructure for AI model training clusters, grew 34% in Q2 — the highest growth rate in 18 months.

Eli Lilly (LLY) gained 3.9% pre-market to $962.17 on strong Phase 3 trial data released over the weekend for their Alzheimer's disease treatment candidate. The trial showed a 28% slowing of cognitive decline in early symptomatic Alzheimer's patients, exceeding the primary efficacy endpoint and positioning the company for a potential FDA submission within 12 months. This is LLY's second major biotech catalyst in as many weeks.

Applied Materials (AMAT) is up 4.3% pre-market to $178.51, riding coattails from Nvidia's strength and positive semiconductor equipment demand signals. The semiconductor equipment supplier is benefiting from accelerated capital spending plans announced by chip manufacturers preparing for next-generation AI chip production cycles in 2027.

Pre-Market Movers: Key Levels to Watch Today

Nvidia ($142.34 pre-market, +6.2%) — Support is forming at the 50-day moving average of $138.20. Resistance sits at Friday's close of $134.12, which could now act as secondary support if there's profit-taking at the open. The 200-day MA at $131.50 represents strong institutional support. If NVDA opens above $140, watch for a break toward the 52-week high of $156.78 set in May. Pre-market volume of 12.8M is 2.9x average, suggesting this move has conviction behind it.

Pfizer ($31.18 pre-market, +4.7%) — The $30.50 level is now support after Friday's close at $29.75. Resistance is at the 52-week high of $33.20, set in June 2025. The 50-day moving average sits at $29.12 — now a key level to defend on any pullback. Pfizer's pre-market volume of 5.4M shares is 2.1x average, indicating moderate institutional accumulation.

Broadcom ($189.42 pre-market, +5.1%) — Key support at the 200-day MA of $182.30. Resistance forming at $192.50 (Friday's intraday high). The 50-day MA sits at $185.20. If AVGO sustains above $190 at the open, the next resistance target is the 52-week high of $198.90. Pre-market volume of 3.2M is elevated, signaling institutional buying interest.

Eli Lilly ($962.17 pre-market, +3.9%) — Support at the 50-day moving average of $948.30. Resistance at the 52-week high of $1,012.50, set in July 2026. LLY has been in a consolidation pattern between $920 and $980 for the past three weeks — this pre-market move could trigger a breakout. Volume at 1.8M shares is 2.3x average.

Applied Materials ($178.51 pre-market, +4.3%) — Support at $173.20 (50-day MA). Resistance at Friday's intraday high of $181.50. The 200-day MA sits at $169.80. If AMAT clears $180 at the open, momentum traders will likely target the 52-week high of $192.30.

What Analysts Say About Today's Pre-Market Movers

Nvidia: Goldman Sachs maintains its Buy rating with a $165 price target, implying 16% upside from current pre-market levels. The $8.2B order announcement validates Goldman's thesis that AI infrastructure spending will exceed $600B cumulatively through 2028. Morgan Stanley reiterated Overweight with a $155 target. Consensus among 42 analysts: 37 Buy, 5 Hold, 0 Sell. Average price target: $159.20, or 12% upside.

Pfizer: Barclays upgraded PFE to Overweight on Friday afternoon (before the earnings beat) with a $34.50 target. The oncology acceleration validates management's investment thesis. SVB Securities initiated coverage with an Outperform rating and a $36 target. Consensus among 28 analysts: 18 Buy, 8 Hold, 2 Sell. Average price target: $33.80, or 8.4% upside from pre-market.

Broadcom: Jefferies reiterated Buy with a $210 target. The networking segment's 34% growth is reinvigorating Street estimates. Consensus among 35 analysts: 28 Buy, 7 Hold, 0 Sell. Average price target: $205, or 8.3% upside from current levels.

Eli Lilly: Leerink Partners maintained Outperform with a $1,050 target. The Phase 3 trial success de-risks the FDA pathway and positions LLY as the clear leader in the Alzheimer's treatment space ahead of competitor trials later this year. Consensus among 22 analysts: 20 Buy, 2 Hold, 0 Sell. Average price target: $1,038, or 7.9% upside.

Applied Materials: Mizuho Securities upgraded AMAT to Buy with a $195 target, citing the semiconductor equipment super-cycle thesis. Consensus among 30 analysts: 24 Buy, 6 Hold, 0 Sell. Average price target: $192.30, or 7.7% upside from pre-market.

What's Next for Today's Pre-Market Movers

The market opens at 9:30 a.m. ET in approximately 6.5 hours from this pre-market session. History suggests that stocks moving 5%+ in pre-market on positive catalysts typically see one of three outcomes: (1) gap up and hold, (2) gap up but fade 30-50% of the move into the close, or (3) gap up and continue higher through mid-day before profit-taking in the final hour.

Nvidia's bull case: If the $8.2B order is confirmed by the customer (expected this week), the stock could extend gains toward $150 by Thursday's close. The data center supercycle thesis remains intact, with 2027 revenue potentially exceeding $22B.

Nvidia's bear case: Profit-taking could trigger a 3-4% fade from pre-market highs if the market perceives the order as already priced in. Support at $138 would need to hold to prevent a move back toward $130.

Pfizer's next catalyst: Earnings season accelerates this week with tech and healthcare companies reporting through Thursday. For PFE specifically, investor focus shifts to the company's Phase 3 trial readout on their GLP-1 competitor drug, expected in September. The stock's momentum could attract technical buyers if it sustains above $31 at the open.

Broadcom's next catalyst: The company hosts an investor day on September 5, where management is expected to outline the networking revenue growth trajectory through 2028. This could provide the next catalyst for the stock to move higher or consolidate.

For a deeper understanding of how pre-market moves translate to full-day performance, see our guide to understanding volume in stocks and how volume spikes predict opening volatility. You can also track all these movers on the Nvidia stock page, Pfizer stock page, and Broadcom stock page.

Frequently Asked Questions

Why are stocks moving in the pre-market session today?
Pre-market moves are driven by after-hours news announced Friday evening or over the weekend. Today's movers include Nvidia's $8.2B accelerator order, Pfizer's earnings beat, Broadcom's guidance raise, and Eli Lilly's Phase 3 trial success. Pre-market volume on these movers is 2.1x to 3.8x average, indicating institutional positioning before the 9:30 a.m. open.

Do pre-market gains hold once the market opens?
Statistically, stocks that gap up 5%+ on positive catalysts hold 60-70% of their pre-market gains through the first hour of trading, then experience 15-30% profit-taking by the 2 p.m. close. However, stocks with high pre-market volume (3x+ average) tend to hold better because it reflects institutional buying, not just retail momentum-chasing.

Should I buy these stocks at the open?
That's a personal decision based on your investment thesis, risk tolerance, and portfolio allocation. What we can tell you: analyst consensus on all five of today's movers is heavily skewed toward Buy ratings, and average price targets suggest 7-16% additional upside over the next 6-12 months. However, gaps can reverse if profit-taking emerges at the open.

What is the 50-day moving average and why does it matter?
The 50-day MA is a key technical support and resistance level that represents the average closing price over the past 50 trading days. When a stock opens above its 50-day MA on strong volume, it signals institutional buyers are stepping in. When it falls below, it often triggers stop-loss selling.

Where can I track these movers throughout the day?
Use the earnings calendar to track earnings surprises and upcoming catalysts. Check individual stock pages for real-time price updates and technical analysis throughout the trading day.